Ganot Ilan 4

What Happened
Ilan Ganot, a director of Solid Biosciences (SLDB), sold 7,205 shares on February 4, 2026, for total proceeds of $46,414. The reported weighted-average price was $6.44 per share (sales executed in multiple trades at prices between $6.28 and $6.60). This was a sale (not a purchase) and was executed as a sell‑to‑cover to satisfy withholding taxes associated with the vesting of previously granted restricted stock units.

Key Details

• Transaction date: February 4, 2026 (reported on Form 4 filed Feb 6, 2026).
• Shares sold: 7,205; weighted-average price: $6.44; price range: $6.28–$6.60; proceeds: $46,414.
• Shares owned after the transaction (per footnotes): 95,255 shares held individually, 4,042 held jointly with Annie Ganot, and 19,394 held in an irrevocable trust—totaling 118,691 beneficially reported shares.
• Footnote highlights: sale was a non‑discretionary sell‑to‑cover to satisfy tax withholding for vested RSUs (durable automatic sales instruction adopted Sept 25, 2024). The filer can provide per‑trade price breakdown on request.
• Timeliness: Filing appears timely (transaction 2/4/2026; Form 4 filed 2/6/2026).

Context
This was a routine sell‑to‑cover related to RSU vesting (tax withholding), not an opportunistic open‑market trade. Such transactions typically reflect tax obligations rather than a change in an insider’s view of the company; purchases by insiders are generally considered more informative about insider sentiment.